By Steve Moore | Friday 27 May 2022
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
RUA Life Sciences (RUA) states that it “is pleased to provide an update for the year ended 31 March 2022 together with current trading, regulatory and operational updates, ahead of the publication of the group's audited final results for the year ended 31 March 2022, which are expected to be released mid-July”. So what of a current 7.5% lower share price at 43p?...